Integrated Diagnostics (UK) Market Value
| IDHC Stock | 0.40 0.02 5.26% |
| Symbol | Integrated |
Integrated Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Integrated Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Integrated Diagnostics.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Integrated Diagnostics on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Integrated Diagnostics Holdings or generate 0.0% return on investment in Integrated Diagnostics over 30 days. Integrated Diagnostics is related to or competes with National Beverage, Qurate Retail, Bell Food, Supermarket Income, Edita Food, Sligro Food, and Monster Beverage. Integrated Diagnostics is entity of United Kingdom More
Integrated Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Integrated Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Integrated Diagnostics Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.07 | |||
| Information Ratio | 0.0039 | |||
| Maximum Drawdown | 22.72 | |||
| Value At Risk | (4.35) | |||
| Potential Upside | 5.88 |
Integrated Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Integrated Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Integrated Diagnostics' standard deviation. In reality, there are many statistical measures that can use Integrated Diagnostics historical prices to predict the future Integrated Diagnostics' volatility.| Risk Adjusted Performance | 0.0379 | |||
| Jensen Alpha | 0.1403 | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.0034 | |||
| Treynor Ratio | (1.32) |
Integrated Diagnostics Backtested Returns
Currently, Integrated Diagnostics Holdings is out of control. Integrated Diagnostics holds Efficiency (Sharpe) Ratio of 0.0516, which attests that the entity had a 0.0516% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Integrated Diagnostics, which you can use to evaluate the volatility of the firm. Please check out Integrated Diagnostics' Risk Adjusted Performance of 0.0379, downside deviation of 4.07, and Market Risk Adjusted Performance of (1.31) to validate if the risk estimate we provide is consistent with the expected return of 0.18%. Integrated Diagnostics has a performance score of 4 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.0975, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Integrated Diagnostics are expected to decrease at a much lower rate. During the bear market, Integrated Diagnostics is likely to outperform the market. Integrated Diagnostics right now retains a risk of 3.58%. Please check out Integrated Diagnostics maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if Integrated Diagnostics will be following its current trending patterns.
Auto-correlation | 0.17 |
Very weak predictability
Integrated Diagnostics Holdings has very weak predictability. Overlapping area represents the amount of predictability between Integrated Diagnostics time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Integrated Diagnostics price movement. The serial correlation of 0.17 indicates that over 17.0% of current Integrated Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | -0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Integrated Diagnostics lagged returns against current returns
Autocorrelation, which is Integrated Diagnostics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Integrated Diagnostics' stock expected returns. We can calculate the autocorrelation of Integrated Diagnostics returns to help us make a trade decision. For example, suppose you find that Integrated Diagnostics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Integrated Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Integrated Diagnostics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Integrated Diagnostics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Integrated Diagnostics stock over time.
Current vs Lagged Prices |
| Timeline |
Integrated Diagnostics Lagged Returns
When evaluating Integrated Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Integrated Diagnostics stock have on its future price. Integrated Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Integrated Diagnostics autocorrelation shows the relationship between Integrated Diagnostics stock current value and its past values and can show if there is a momentum factor associated with investing in Integrated Diagnostics Holdings.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.